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Caspase-1 Cleaves Interleukin (IL)-1b and IL-18
Once Activated in Inflammasomes
Innate immune cells such as macrophages and dendritic cells
produce potent inflammatory cytokines to mount an appropriate
immune response against microbial threats. The related cytokines
interleukin (IL)-1b and IL-18 are generated as cytosolic precursors
that require cleavage by the cysteine protease caspase-1 to
generate biologically active IL-1b and IL-18. Hence, mice lacking
caspase-1 are defective in the maturation and secretion of IL-1b
and IL-18 [1]. Caspase-1 itself is generated as an inactive
precursor protein that contains a ‘‘caspase activation and
recruitment domain’’ (CARD) motif in its N-terminus, which is
essential for bringing two or more zymogens sufficiently close to
induce their autocatalytic activation, a process believed to occur in
large cytosolic protein complexes termed ‘‘inflammasomes’’.
Most inflammasomes contain a member of the nucleotide binding
and oligomerization domain (NOD)-like receptor (NLR) family.
These proteins are thought to function as sensors that detect
conserved microbial components in intracellular compartments,
similar to the role of mammalian Toll-like receptors (TLRs) at the
cell surface and within endosomes [2]. NLRs share a domain
organization that usually includes (1) an amino-terminal protein–
protein interaction domain such as a CARD or pyrin domain; (2) an
intermediary NACHT domain that is required for nucleotide binding
and self-oligomerization; and (3) a variable number of carboxy-
terminal leucine-rich repeat (LRR) motifs involved in sensing
pathogen molecules. In general, the pathogen-associated molecular
patterns (PAMPs) recognized by NLRs and TLRs are vital for
microbial survival, representing either nucleic acid structures unique
to microbes or cell wall components alien to mammalian cells.
The bipartite adaptor protein ASC plays a central role in the
interaction between NLRs and caspase-1 in each of these
inflammasome complexes. As a consequence, caspase-1 activation
and the production of IL-1b and IL-18 are abolished in ASC-
deficient macrophages that are infected with intracellular bacteria
or stimulated with a combination of microbial ligands and ATP [3].
ASC has a specific role in caspase-1 activation because secretion of
the cytokines TNF-a and IL-6 is not affected by ASC deficiency.
Genetic studies in mice suggest that at least four inflammasomes
of distinct composition are formed in vivo in a stimulus-dependent
manner (Figure 1): the IPAF inflammasome [3–5], the NALP1
inflammasome [6], the Cryopyrin/NALP3 inflammasome [7–9],
and a fourth inflammasome triggered by Francisella tularensis
infection [8,10]. Biochemical studies suggested the existence of
an additional inflammasome containing NALP2 [11,12], although
specific ligands for this inflammasome remain to be identified. In
addition to these NLRs, the HIN-200 protein absent in melanoma
2 (AIM2) was recently shown to trigger caspase-1 activation in
response to cytoplasmic double-stranded DNA (dsDNA) [13–16].
The IPAF Inflammasome
Caspase-1 activation is largely abolished in IPAF-deficient macro-
phages infected with Salmonella typhimurium [3–5], Legionella pneumophila
[17,18], Pseudomonas aeruginosa [19–21], or Shigella flexneri [22]. Bacterial
flagellin, which typically is translocated into the cytosol by a bacterial
secretion system (type III for S. typhimurium and P. aeruginosa;t y p eI Vf o r
L. pneumophila), was identified as the bacterial compound that is sensed
by IPAF. S. flexneri lacks flagellin, however, so the nature of the S. flexneri
factor that is sensed by IPAF is unknown. Nevertheless, the finding that
recombinant purified flagellin induces IPAF-dependent caspase-1
activation when delivered to the cytosol, either using pore-forming
proteins or upon transfection with cationic lipids, indicates that
cytosolic flagellin is sufficient for IPAF activation regardless of its
delivery mechanism [4,5,23]. Interestingly, the extracellular flagellin
receptor TLR5 is not required for IPAF-mediated detection of
cytosolic flagellin and the subsequent activation of caspase-1 [4,5],
suggesting that TLR5 and IPAF have evolved to control distinct
signalling pathways (NF-kB activation and caspase-1 activation,
respectively) when the host is infected with intracellular pathogens.
The NALP1 Inflammasome
The Bacillus anthracis lethal toxin (LT) consists of a pore-forming
protective antigen (PA) subunit and a metalloprotease subunit lethal
factor (LF). PA allows delivery of LF into the cytosol of infected cells
[24]. Macrophages from C57BL/6J and multiple other inbred mice
strains are resistant to LT-induced death, whereas 129/S1
macrophages are highly susceptible. Mutations in the Nalp1b gene
wereidentifiedasthekeydeterminantofLTsusceptibilityinmice[6].
Five distinct Nalp1b alleles were identified in 18 mouse strains
analyzed, demonstrating the extremely polymorphic nature of the
Nalp1b gene [6]. Two alleles were found in the susceptible mouse
strains, whereas the remaining three alleles correlated with LT
resistance. In addition, morpholinos targeting NALP1b rendered LT-
sensitive macrophages resistant to killing. Importantly, LT-induced
toxicity was restored in C57BL/6 macrophages by expressing the
susceptible Nalp1b allele from a 129/S1-derived bacterial artificial
chromosome (BAC) [6]. This study established that a functional
Nalp1b allele is required for LT to induce cell death in mouse
macrophages. Interestingly, caspase-1 is activated in LT-sensitive but
not in LT-resistant macrophages. Moreover, caspase-1-deficient
macrophages are protected from LT-induced death, even in the
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activity of the anthrax LF subunit was shown to be required for
NALP1b-mediated caspase-1 activation [25], but the identity of the
LF substrate(s) that are processed in order for caspase-1 to be
activated remains obscure.
The Cryopyrin/NALP3 Inflammasome
Gain-of-function mutations within the NACHT domain of the
NLR protein Cryopyrin/NALP3 are associated with three
autoinflammatory disorders characterized by skin rashes and
prolonged episodes of fever in the absence of any apparent
infection. These hereditary periodic fever syndromes are Muckle-
Wells syndrome (MWS), familial cold autoinflammatory syndrome
(FACS), and neonatal-onset multisystem inflammatory disease
(NOMID), and they are collectively referred to as the Cryopyrin/
NALP3-associated periodic syndromes (CAPS) [12]. Functional
studies revealed that the disease-associated Cryopyrin/NALP3
mutations enhance caspase-1 activation and IL-1b secretion [26].
Indeed, mononuclear cells from CAPS patients spontaneously
Figure 1. Stimuli and composition of distinct inflammasomes. The NLR proteins NALP1b, Cryopyrin/NALP3, and IPAF and the HIN-200 protein
AIM2 assemble a caspase-1 activating inflammasome complex in response to specific microbial or bacterial factors. The murine NALP1b
inflammasome recognizes the cytosolic presence of anthrax LT. The Cryopyrin/NALP3 inflammasome recognizes multiple PAMPs in combination with
ATP or nigericin, as well as crystalline substances including MSU, silica, and asbestos particles. The IPAF inflammasome senses Salmonella and
Legionella flagellin and a yet unidentified Shigella flexneri compound, which all access the cytosol through a type III or IV secretion system. Cytosolic
PAMPs may trigger assembly of a particular inflammasome complex by causing modifications in unknown host factors (X, Y, Z) that are monitored by
specific NLR proteins. In contrast, AIM2 directly binds dsDNA in the cytosol to induce caspase-1 activation. The CARD/pyrin-containing adaptor
protein ASC is essential for all these inflammasome complexes, although its role in the NALP1b inflammasome remains to be formally established.
Once activated, caspase-1 processes the IL-1b and IL-18 precursors into the mature cytokines, which are secreted through an unknown mechanism.
doi:10.1371/journal.ppat.1000510.g001
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proved to be an effective treatment for these autoinflammatory
syndromes [27]. In addition to the CAPS-associated mutations in
Cryopyrin/NALP3, polymorphisms in regulatory elements that
cause decreased Cryopyrin/NALP3 expression and IL-1b pro-
duction were recently linked with increased susceptibility to
Crohn’s disease in humans [28].
Human monocytes constitutively express active caspase-1 and
only require stimulation with TLR ligands such as LPS,
peptidoglycan, or microbial RNA for secretion of mature IL-1b
[29]. In contrast, co-exposure to millimolar concentrations of ATP
is required for activation of the Cryopyrin/NALP3 inflammasome
in primary human and mouse macrophages, dendritic cells, and the
leukemic cell line THP-1 [7–9,29]. ATP triggers opening of the
non-selective cation channel of the purinergic P2X7 receptor, and
this is followed by the gradual opening of a larger pore attributed to
the hemichannel pannexin-1, which is recruited upon P2X7
receptor activation [30–33]. Knockdown and pharmacological
inhibition of pannexin-1 indicates that the hemichannel protein is
critical for Cryopyrin/NALP3-dependent caspase-1 activation and
IL-1b secretion in response to LPS+ATP [32]. Cryopyrin/NALP3
also mediates caspase-1 activation in macrophages infected with
Staphylococcus aureus or adenovirus [8,34]. In addition, medically
relevant crystals such as monosodium urate (MSU), calcium
pyrophosphate dihydrate (CPPD), crystalline asbestos, and silica
were shown to induce Cryopyrin/NALP3-dependent activation of
caspase-1. The Cryopyrin/NALP3 inflammasome was hence
suggested to participate in the aetiology of gout, pseudogout,
asbestosis, and silicosis [35–38]. Moreover, the Cryopyrin/NALP3
inflammasome was proposed to be required for antibody produc-
tion with alum-containing vaccines [39–41], but this has been
disputed by others [42,43]. Because of this plethora of molecularly
diverse agonists, activation of the Cryopyrin/NALP3 inflamma-
some is widely believed to involve the generation/activation of a
common secondary messenger. Although the precise nature of this
factor remains elusive, several mechanisms have been suggested,
including K
+ efflux [44,45], lysosomal destabilization [37], and the
generation of reactive oxygen species [36,38].
The AIM2 Inflammasome
Transfection of dsDNA was recently shown to induce caspase-1
activation through the HIN-200 family member AIM2 [13–16].
The HIN domain in AIM2’s C-terminus directly interacts with
dsDNA, whereas the N-terminal pyrin domain recruits caspase-1
through ASC. Interestingly, the dsDNA vaccinia virus relies on the
AIM2 inflammasome for caspase-1 processing [16], whereas
DNA-dependent activation of caspase-1 by adenoviral particles
required Cryopyrin/NALP3 [34]. Studies with additional dsDNA
viruses may reveal the intricacies of these inflammasomes.
The Francisella-Sensing Inflammasome
The Gram-negative coccobacillus Francisella tularensis is the
causative agent of tularaemia. Infected mice lacking ASC or
caspase-1 show markedly increased bacterial burden and mortality
when compared to their wild-type counterparts, indicating that
caspase-1 activation plays a vital role in the normal immune
response to this pathogen [10]. F. tularensis mutants that cannot
escape the vacuole are incapable of activating caspase-1, thus
linking phagosomal escape to caspase-1 activation [46]. Type I
interferon signalling functions upstream of F. tularensis–induced
caspase-1 activation [47], which further requires ASC, but neither
Cryopyrin/NALP3 nor IPAF [8,10]. This suggests the existence of
a separate F. tularensis–sensing inflammasome.
Concluding Remarks
Itisevidentthatinflammasomesfulfillimportantrolesintheinnate
immune response. An open question that currently drives inflamma-
some research is how inflammasomes are activated. One possibility is
a direct ligand–receptor interaction, as recently shown for activation
of the AIM2 inflammasome by cytosolic dsDNA [13–16]. Activation
of other inflammasomes may also be direct or rather rely on the
generation of a secondary messenger that is recognized by a specific
inflammasome (Figure 1). However, the molecular nature of such
cellular ‘‘danger signals’’ remains an enigma. Elucidating how
inflammasomes are activated will provide new insights into the
mechanisms governing immunity and may pave the way for new
therapeutic approaches for autoimmune disorders.
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